Generic Semaglutide Pricing Could Disrupt Global Markets

Discover the potential of Generic Semaglutide Pricing, where new research shows significant savings on weight-loss medications.
GLP-1 Medicines Review: South Africa Moves to Expand Access
NEMLC begins a GLP-1 medicines review to assess affordability and potential inclusion in the public health sector for diabetes and obesity
A decade of transformation in obesity treatment
ObesityWeek 2024 attracted unprecedented attention from Wall Street, highlighting obesity treatment's booming pharmaceutical industry.
Aspen secures licensing agreement to enter GLP-1 market
Aspen Pharmacare has secured a licensing agreement to enter the GLP-1 agonist market, positioning it for growth in diabetes and obesity treatment solutions.